Characterization of orofacial features in sclerodermatous chronic graft-versus-host disease

被引:1
|
作者
Bajonaid, Amal [1 ,12 ]
Guntaka, Praveen Kumar [2 ]
Harper, Matthew [3 ,4 ]
Cutler, Corey [5 ]
Duncan, Christine [6 ]
Villa, Alessandro [7 ,8 ,9 ]
Sroussi, Herve Y. [10 ,11 ]
Woo, Sook-Bin [10 ,11 ]
Treister, Nathaniel S. [10 ,11 ]
机构
[1] Jazan Univ, Coll Dent, Jazan, Saudi Arabia
[2] Mt Sinai Hlth Syst, New York, NY USA
[3] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA
[4] Boston Childrens Hosp, Dept Dent, Boston, MA USA
[5] Dana Farber Canc Inst, Div Stem Cell Transplantat & Cellular Therapy, Boston, MA USA
[6] Dana Farber Boston Childrens Canc & Blood Disorder, Boston, MA USA
[7] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA USA
[8] Herbert Wertheim Coll Med, Miami, FL USA
[9] Miami Canc Inst, Miami, FL USA
[10] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA USA
[11] Brigham & Womens Hosp, Div Oral Med & Dent, Boston, MA USA
[12] Jazan Univ, Coll Dent, Dept Oral & Maxillofacial Surg & Diagnost Sci, Al Maarefah Rd, Jazan, Saudi Arabia
关键词
face; graft-versus-host disease; oral cavity; sclerosis; CONSENSUS DEVELOPMENT PROJECT; RISK-FACTORS; PHOTOBIOMODULATION THERAPY; CELL TRANSPLANTATION; ORAL INVOLVEMENT; CLINICAL-TRIALS; CHRONIC GVHD; RECOMMENDATIONS; CRITERIA; PATHOGENESIS;
D O I
10.1111/odi.14932
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BackgroundChronic graft-versus-host disease (cGVHD) is a leading cause of morbidity and mortality following allogeneic hematopoietic cell transplantation (alloHCT). The sclerodermatous form of cGVHD can be particularly debilitating; however, orofacial sclerodermatous involvement remains poorly described. ObjectiveTo characterize orofacial features of sclerodermatous cGVHD in a single center cohort of patients who underwent alloHCT. Study DesignRetrospective data were collected from electronic medical records and analyzed descriptively. ResultsThere were 39 patients who received alloHCT between 1993 and 2017 and developed orofacial sclerodermatous cGVHD. Concomitant cutaneous sclerodermatous cGVHD was common (n = 20, 51%). Orofacial sclerodermatous cGVHD features included fibrous bands of the buccal mucosa (n = 23, 59%), limited mouth opening (n = 19, 54%), perioral fibrosis (n = 8, 21%), and focal gingival recession (n = 4, 10%). Oral mucosal fibrosis was observed at the site of active or resolved chronic lichenoid inflammation in 30 patients, with all but two also presenting with a history of ulcerations. Management included jaw stretching exercises (n = 10; 6 stable/improved), surgery (n = 3; 2 improved), and intralesional corticosteroid injections (n = 2; 2 improved). ConclusionsOrofacial involvement with sclerodermatous cGVHD can present with multiple manifestations including fibrous banding, limited mouth opening, perioral fibrosis, and focal gingival recession. Surgical and non-surgical management strategies may improve clinical function and reduce morbidity.
引用
收藏
页码:5082 / 5090
页数:9
相关论文
共 50 条
  • [1] CHRONIC SCLERODERMATOUS GRAFT-VERSUS-HOST DISEASE
    MULLERSERTEN, B
    VAKILZADEH, F
    HAUTARZT, 1994, 45 (11): : 772 - 775
  • [2] Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease
    Namdaroglu, S.
    Iskender, D.
    Dal, M. S.
    Cakar, M. K.
    Tekgunduz, E.
    Altuntas, F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (01): : 12 - 18
  • [3] Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease
    Belle, Ludovic
    Fransolet, Gilles
    Somja, Joan
    Binsfeld, Marilene
    Delvenne, Philippe
    Drion, Pierre
    Hannon, Muriel
    Beguin, Yves
    Ehx, Gregory
    Baron, Frederic
    PLoS One, 2016, 11 (12):
  • [4] Biomarker Panel for Chronic Graft-Versus-Host Disease
    Yu, Jeffrey
    Storer, Barry E.
    Kushekhar, Kushi
    Abu Zaid, Mohammad
    Zhang, Qing
    Gafken, Philip R.
    Ogata, Yuko
    Martin, Paul J.
    Flowers, Mary E.
    Hansen, John A.
    Arora, Mukta
    Cutler, Corey
    Jagasia, Madan
    Pidala, Joseph
    Hamilton, Betty K.
    Chen, George L.
    Pusic, Iskra
    Lee, Stephanie J.
    Paczesny, Sophie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (22) : 2583 - U57
  • [5] Treatment of chronic graft-versus-host disease in 2011
    Inamoto, Yoshihiro
    Flowers, Mary E. D.
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) : 414 - 420
  • [6] Pulp Obliteration in a Patient with Sclerodermatous Chronic Graft-versus-Host Disease
    Ferreira Gomes, Camilla Borges
    Treisten, Nathaniel Simon
    Millen, Brian
    Armand, Philippe
    Friedland, Bernard
    JOURNAL OF ENDODONTICS, 2016, 42 (04) : 678 - 680
  • [7] Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease
    Doanh Le Huu
    Kimura, Hiroshi
    Date, Mutsumi
    Hamaguchi, Yasuhito
    Hasegawa, Minoru
    Khang Tran Hau
    Fujimoto, Manabu
    Takehara, Kazuhiko
    Matsushita, Takashi
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 74 (03) : 214 - 221
  • [8] Imatinib for refractory chronic graft-versus-host disease with fibrotic features
    Olivieri, Attilio
    Locatelli, Franco
    Zecca, Marco
    Sanna, Adele
    Cimminiello, Michele
    Raimondi, Roberto
    Gini, Guido
    Mordini, Nicola
    Balduzzi, Adriana
    Leoni, Pietro
    Gabrielli, Armando
    Bacigalupo, Andrea
    BLOOD, 2009, 114 (03) : 709 - 718
  • [9] Diagnosis and management of chronic graft-versus-host disease
    Dignan, Fiona L.
    Amrolia, Persis
    Clark, Andrew
    Cornish, Jacqueline
    Jackson, Graham
    Mahendra, Prem
    Scarisbrick, Julia J.
    Taylor, Peter C.
    Shaw, Bronwen E.
    Potter, Michael N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (01) : 46 - 61
  • [10] Disability Related to Chronic Graft-versus-Host Disease
    Hamilton, Betty K.
    Storer, Barry E.
    Wood, William A.
    Pidala, Joseph A.
    Cutler, Corey S.
    Martin, Paul J.
    Chen, George
    Flowers, Mary E.
    Lee, Stephanie J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (04) : 772 - 777